28
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Progress in vitreoretinal surgery for proliferative diabetic retinopathy

, &
Pages 31-40 | Published online: 02 Jul 2009

References

  • Michels RG. Proliferative diabetic retinopathy. Patho- physiology of extraretinal complications and principles of vitreous surgery. Retina. 1981;1:1–17.
  • The DRVS Research Group. Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. DRVS Report 2. Arch Ophthalmol. 1985;103:1644–1652.
  • Michels RG, Rice TA, Rice EF. Vitrectomy for diabetic vit- reous hemorrhage. Am J Ophthalmol. 1983;95:12–21.
  • Michaels RG. Vitrectomy for complications of diabetic retinopathy. Arch Ophthalmol. 1978;96:237–246.
  • The DRVS Study Group. Early vitrectomy for severe pro- liferative diabetic retinopathy in eyes with useful vision. DRVS Report 3. Ophthalmology. 1988;95:1307–1320.
  • DRVS Research Group. Early vitrectomy for severe vitre- ous hemorrhage in diabetic retinopathy. Four year results of a randomized trial. DRVS Report 5. Arch Ophthalmol. 1990;108:958–964.
  • Cohen HB, Mc Meel JW, Franks EP. Diabetic traction detachment. Arch Ophthalmol. 1979;97:1268–1537.
  • D’Amico DJ. Diabetic traction retinal detachments threat- ening the fovea and panretinal argon laser photocoagula- tion. Semin Ophthalmol. 1991;6(1):11–18.
  • Meredith TA, Kaplan HJ, Aaberg TM. Pars plana vitrec- tomy techniques for relief of epiretinal traction by mem- brane segmentation. Am J Ophthalmol. 1980;89:408–413.
  • Charles S. Vitreous microsurgery. Baltimore, Williams and Wilkins, 1981, p. 115.
  • Abrams GW, Williams GA. “En block” excision of diabetic membranes. Am J Ophthalmol. 1987;103:302–308.
  • Rice TA, Michaels RG, Rice EF. Vitrectomy for diabetic traction retinal detachmnent involving the macula. Am J Ophthalmol. 1983;95:22–33.
  • Hutton WL, Bernstein I, Fuller D. Diabetic traction retinal detachment: Factors influencing final visual acuity. Oph- thalmology. 1980;87:1071–1077.
  • Aaberg TM. Pars plana vitrectomy for diabetic traction retinal detachment. Ophthalmology. 1981;88:639–642.
  • Rice TA, Michaels RG, Rice EF. Vitrectomy for diabetic rhegmatogenous retinal detachment. Am J Ophthalmol. 1983;95:34–44.
  • O’Hanley GP, Canny CLB. Diabetic dence premacular hemorrhage. Ophthalmology. 1985;92:507–511.
  • Ramsay RC, Knobloch WH, Cantrill HL. Timing of vitrec- tomy for active Proliferative diabetic retinopathy. Ophthal- mology. 1986;93:283–289.
  • Lewis H, Abrams GW, Williams GA: Anterior hyaloidal fibrovascular proliferation after diabetic vitrectomy. Am J Ophthalmol. 1987;104:607–613.
  • Lewis H, Abrams GW, Foos RY: Clinicopathologic findings in anterior hyaloidal fibrovascular proliferation after diabetic vitrectomy. Am J Ophthalmol. 1987;104:614– 618.
  • Campbell DG, Simmons RJ, Grant WM: Ghost cells as a cause of glaucoma. Am J Ophthalmol. 1976;81:441–450.
  • Campbell DG. Ghost cell glaucoma following trauma. Ophthalmology. 1981;88:1151–1158.
  • Brazitikos PD, D’Amico DJ, Bernal MT, Walsh AW. Erbium:YAGlaser surgery of the vitreous and retina. Oph- thalmology. 1995;102(2):278–290.
  • D’Amico DJ, Brazitikos PD, Marcellino GR, Finn SM, Hobart JL. Initial clinical experience with an erbium: YAGlaser for vitreoretinal surgery. Am J Ophthalmol. 1996; 121(4):414–425
  • D’Amico DJ, Blumenkranz MS, Lavin MJ, Quiroz- Mercado H, Pallikaris IG, Marcellino GR, Brooks GE. Multicenter clinical experience using an erbium: YAGlaser for vitreoretinal surgery. Ophthalmology. 1996;103:1575–1585.
  • Binder S, Stolba U, Kellner L, Krebs I. Erbium:YAG laser vitrectomy: clinical results. Am J Ophthalmol. 2000;130:82–86.
  • Petersen H, Mrochen M, Seiler T. Comparison of erbium: yttrium-aluminum-garnet-laservitrectomy and mechanical vitrectomy: a clinical study. Ophthalmology. 2000;107:1389–1392.
  • Faulborn J. Treatment of giant tears after perforating injuries with vitrectomy and a cyanoacrylate tissue adhe- sive. Adv Ophthalmol. 1976;33:204–207.
  • McCuen BW II, Hida T, Sheta SM. Transvitreal cyano- acrylate retinopexy in the management of complicated retinal detachment. Am J Ophthalmol. 1987;104:127– 132.
  • Sheta SM, Hida T, McCuen BW II. Cyanoacrylate tissue adhesive in the management of recurrent retinal detachment caused by macular hole. Am J Ophthalmol. 1990;109:28– 32.
  • Hanneken A, de Juan E Jr, McCuen BW II. The manage- ment of retinal detachments associated with choroidal colobomas by vitreous surgery. Am J Ophthalmol. 1991; 111:271–275.
  • Hartent ME, Hirose T. Cyanoacrylate glue in the repair of retinal detachment associated with posterior retinal breaks in infants and children. Retina. 1998;18:125–129.
  • Matsumoto T, Hardaway RM, Pani KC et al. Aron alpha a Sanyo, Japanese tissue adhesive in surgery of internal organs. Am Surg. 1968;24:263–267.
  • Tanaka M, Qui H, Hadeyama T et al. Enzyme assisted vitrectomy with hyaluronidase. XXI Gonin Club Meeting 1998;17 (abstr).
  • Karagozian HL, Karagozian VK. Hyaluronidase for intrav- itreal use in an animal model. Invest Ophthalmol Vis Sci. 1997;38(s):662 (abstr).
  • Verstraeten T, Chapman C, Hartzer M et al. Pharmacologic induction of PVD in the rabbit. Arch Ophthalmol. 1993; 111:849–854.
  • Williams GA, Chow DR, Trese MT et al. Successful closure of traumatic macular holes without adjutant. XXI Gonin Club Meeting. 1998;31 (abstr).
  • Trese MT, Williams GA, Hartzek MK. A new approach to stage 3 macular hole. Ophthalmology. 2000;107:1607– 1611.
  • Tezel TH, Priore LVD, Kaplan HJ. Posterior vitreous detachment with dispace. Retina. 1998;18:7–15.
  • Hageman GS, Ressel SR. Chondroitinase-mediated disin- section of the primate vitreous body. Invest Ophthalmol Vis Sci. 1994;35(s):1260 (abstr).
  • Tanaka M, Hadeyama T, Takahashi K et al. Studies on enzyme assisted vitrectomy with hyaluronidase. Invest Ophthalmol Vis Sci. 1995;36(s):656.
  • Harooni M, McMillan T, Refojo M. Efficacy and safety of enzymatic posterior vitreous detachment by intravitreal injection of hyaluronidase. Retina. 1998;18:16–22.
  • Tanaka M, Qui H, Hadeyama T et al. Enzyme assisted vit- rectomy with hyaluronidase. XXI Gonin Club Meeting. 1998;17 (abstr).
  • Karagozian HL, Karagozian VK. Hyaluronidase for intrav- itreal use in an animal model. Invest Ophthalmol Vis Sci. 1997;38(s):662 (abstr).
  • Hesse L, Chofflet J, Kroll P. Tissue plaminogen activator as a biochemical adjuvant in vitrectomy for proliferative dia- betic vitreoretinopathy. Ger J Ophthalmol. 1995;4:323– 327.
  • Hesse L, Kroll P. Enzymatically induced posterior vitreous detachment in proliferative diabetic vitreoretinopathy. Klin Monatsbl Augenheilkd. 1999;214:84–89.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.